Benjamin “Beno” Freedman has been named STEM CELLS' Young Investigator of 2018 for his groundbreaking work with organoids in studying kidney structure and disease.
For almost 50 years, hemodialysis has extended lives of people with chronic kidney disease. But when a patient first learns that their kidneys have failed and dialysis is necessary to survive, it can be a jolting overture of mortality.
Nearly one in 10 patients with end-stage kidney failure undergoes toe, foot, or leg amputation in their last year of life. During this time, these patients have prolonged stays in healthcare settings and limited access to hospice services.
A large, multiethnic study of healthy individuals found that high blood levels of an inflammatory marker are linked with long-term decline of kidney function.
A new UW Medicine study strongly associates the use of intravenous heroin – in particular the black tar variety popular in the Pacific Northwest – with an untreatable kidney disease that often leads to dialysis and death.
In their last year of life, Medicare patients on chronic kidney dialysis generally follow one of four trajectories of healthcare expense and intensity, new research suggests.
In a study of nearly 6,000 patients with chronic kidney disease and heart failure, the use of implantable cardioverter defibrillators (ICDs) was associated with a significantly increased risk of subsequent hospitalization.
A lab takes human stem cells and helps them develop into kidney structures, which can be tested for response to therapeutics that might subsequently help people manage chronic kidney diseases.
